| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8615869 | Clinical Lymphoma Myeloma and Leukemia | 2017 | 34 Pages |
Abstract
The analysis clearly validated the prognostic effect of the integrative risk score on the outcome in APL patients. The value was further empowered because the single gene analyses did not show similar results. Whether the integrative risk score retains its prognostic power in the chemotherapy-free setting should be investigated further.
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
Anna Hecht, Seraphina Doll, Heidi Altmann, Daniel Nowak, Eva Lengfelder, Christoph Röllig, Gerhard Ehninger, Karsten Spiekermann, Wolfgang Hiddemann, Christel WeiÃ, Wolf-Karsten Hofmann, Florian Nolte, Uwe Platzbecker,